Ascendis Pharma A/S (ASND)

Ascendis Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 9, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,122	8,234	7,125	6,824	7,635	9,007
Market Cap Growth	56.09%	15.57%	4.41%	-10.63%	-15.23%	35.62%
Enterprise Value	13,473	8,416	7,347	6,449	6,676	7,922
Last Close Price	214.77	137.67	125.95	122.13	134.53	166.78
PS Ratio	22.16	21.87	24.17	124.77	863.17	1059.02
PB Ratio	-	-75.24	-44.24	24.25	7.60	8.78
P/TBV Ratio	-	-	-	24.70	7.64	8.84
EV/Sales Ratio	23.38	22.35	24.92	117.92	754.73	931.41
Debt / Equity Ratio	-4.22	-8.10	-4.42	1.93	0.12	0.11
Asset Turnover	0.53	0.36	0.28	0.05	0.01	0.01
Inventory Turnover	0.27	0.18	0.26	0.12	-	-
Quick Ratio	0.66	0.81	0.62	1.06	7.03	13.75
Current Ratio	1.02	1.17	0.95	1.29	8.03	14.02
Return on Equity (ROE)	-	-	-818.43%	-101.69%	-44.54%	-58.36%
Return on Assets (ROA)	-17.16%	-17.38%	-29.73%	-32.29%	-27.35%	-24.95%
Return on Capital (ROIC)	-33.13%	-27.89%	-44.83%	-39.89%	-29.42%	-26.42%
Earnings Yield	-2.43%	-4.75%	-7.47%	-9.13%	-5.71%	-5.69%
FCF Yield	-1.51%	-3.87%	-7.29%	-7.99%	-6.57%	-3.96%
Buyback Yield / Dilution	-4.73%	-2.85%	-0.38%	-2.37%	-8.21%	-8.84%

Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q